To help prevent medical product shortages and ensure access to essential drugs and devices, the Food and Drug Administration should make information on medical product sourcing, manufacturing capacity and quality publicly available for all medical products approved or cleared for sale in the United States, according to a new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine. Among other actions, the report calls for the Office of the Assistant Secretary for Preparedness and Response to develop ways to better manage the Strategic National Stockpile and convene a stakeholder group to improve medical product allocation and delivery during shortages; health systems to incorporate quality and reliability into their contracting, purchasing and inventory decisions; and countries to negotiate an international treaty that prohibits export bans on critical products.

Related News Articles

Headline
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19…
Headline
The House Energy and Commerce Committee held a hearing on legislative proposals to prevent and respond to generic drug shortages. In comments submitted…
Headline
AHA recently voiced support for four bipartisan bills introduced in the Senate to help alleviate the nation’s chronic and growing drug shortages.   …
News
Pfizer will ship certain sterile injectable products directly to customers under an emergency ordering process implemented yesterday due to high demand for the…
Headline
The Food and Drug Administration said it did not expect “any immediate significant impacts on supply” after a tornado damaged a Pfizer plant in North…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…